PlainRecalls
FDA Drug Moderate Class II Terminated

Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/20 mg, a) 30 count (NDC 43598-744-30), b) 90 count (NDC 43598-744-90) bottles, Rx only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA

Reported: November 10, 2021 Initiated: October 5, 2021 #D-0082-2022

Product Description

Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/20 mg, a) 30 count (NDC 43598-744-30), b) 90 count (NDC 43598-744-90) bottles, Rx only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA

Reason for Recall

Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity

Details

Units Affected
a) 30,839 bottles, b) 3,830 bottles
Distribution
Nationwide in the US
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/20 mg, a) 30 count (NDC 43598-744-30), b) 90 count (NDC 43598-744-90) bottles, Rx only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA. Recalled by Dr. Reddy's Laboratories, Inc.. Units affected: a) 30,839 bottles, b) 3,830 bottles.
Why was this product recalled?
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Which agency issued this recall?
This recall was issued by the FDA Drug on November 10, 2021. Severity: Moderate. Recall number: D-0082-2022.